Notifications
Clear all
Topic starter
13/06/2020 2:40 am
https://www.jcancer.org/v10p6543.htm
"These results indicated that EGCG inhibits lung cancer cell proliferation by suppressing NF-κB signaling. Coadministration of EGCG and BAY11-7082 has a synergistic effect both in vitro and in vivo and may serve as a novel therapeutic strategy for lung cancer."
